Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT05321979 · COMPLETED
Trial details
- NCT number
- NCT05321979
- Sponsor
- Medytox Korea
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2023-05-30
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.